medigraphic.com
ISSN 0185-3325 (Print)
Órgano Oficial del Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz

2011, Number 4

<< Back Next >>

Salud Mental 2011; 34 (4)

Revisión sistemática sobre tratamiento de adicciones en México

Rojas E, Real T, García-Silberman S, Medina-Mora ME

Language: Spanish
References: 26
Page: 351-365
PDF size: 148.36 Kb.


ABSTRACT

The consumption of substances with addictive potential is a relevant health problem. In Mexico, the abuse is spreading and the use of services is unfrequent. To extend the offer and accessibility to treatment means to increase the coverage and to guarantee that efficient and effective models are used to treat the patients. The aim of the paper was to learn what has been investigated in this respect; a systematic review of the studies was undertaken to evaluate the treatment research through clinical trials.
Methods: A review of the published literature from 1980 to 2010 in databases and specialized documentation centers was undertaken. Reports of clinical trials to evaluate interventions for the consumption of alcohol, tobacco and drugs were included. The criteria proposed by CONSORT were used as indicators.
Results: Two hundred and twenty publications were located on treatment in Mexico, of which only 26 (11.8 %) corresponded to clinical trials to evaluate the impact of different interventions.
The most used type of treatment was the cognitive-behavioral brief one, followed by its combination with therapy of replacement, pharmacological therapy and individual psychotherapy or group therapy. Trials also included evaluation of motivational brief therapy, the program «La familia enseñante» (teaching family) and psychotherapy, as well as the therapy centered on solutions.
Discussion: Most of the clinical trials localized do not comply with the criteria or do it partially. Additionally they have short scopes due to the limited size of the samples. The results reveal that the reports published of investigations are very scanty to evaluate programs of treatment. There is a need to implement programs of treatment directed to specific populations and to the use of different types of drugs, and to evaluate the interventions.


REFERENCES

  1. Consejo Nacional contra las Adicciones, Instituto Nacional de Psiquiatría Ramón de la Fuente, Instituto Nacional de Salud Pública, Secretaría de Salud. Encuesta Nacional de Adicciones; México; 2008.

  2. Rehm J, Monteiro M. Alcohol consumption and burden of disease in the Americas: implications for alcohol policy. Pan American J Public Health 2005;18(4-5):241-248.

  3. Narro J, Lee G, Gutiérrez H. Daños a la salud y consecuencias sociales por el consumo excesivo de alcohol En: Tapia R Las adicciones dimensión, impacto y perspectiva. Segunda edición. México, DF.: El Manual Moderno; 2001.

  4. Consejo Nacional Contra las Adicciones, Instituto Nacional de Psiquiatría, Dirección General de Epidemiología, Instituto Nacional de Estadística Geografía e Informática. Secretaría de Salud. Encuesta Nacional de Adicciones 2002; México; 2002.

  5. Secretaría de Salud. Sistema Nacional de Vigilancia Epidemiológica (SISVEA). Informe 2009. México, D.F. http://www.dgepi.salud.gob.mx/sis/SISVEA%202009/INFORMES/Informe%20SISVEA2009%20NACIONAL.pdf

  6. Benjet C, Borges G, Medina-Mora ME, Blanco J et al. La Encuesta de Salud Mental en Adolescentes de México. En: Rodríguez JJ, Kohn R, Aguilar-Gaxiola S (eds). Epidemiología de los trastornos mentales en América Latina y el Caribe. Washington, D C: OPS; 2009.

  7. Borges G, Wang PS, Medina-Mora ME, Lara C et al. Delay of first treatment of mental and substance use disorders in Mexico. Am J Public Health 2007;97(9):1638-1643.

  8. Borges G, Medina-Mora ME, Lara MC, Zambrano J et al. Alcohol use and alcohol use disorders in Mexico. Contemp Drug Problems 2007;34(3):389-410.

  9. Kohn R, Levav I. La utilización de los servicios de salud mental y la brecha de tratamiento en América Latina y el Caribe. En: Rodríguez JJ, Kohn R, Aguilar-Gaxiola S (eds.). Epidemiología de los trastornos mentales en América Latina y el Caribe. EUA: OPS; 2009.

  10. Borges G, Medina-Mora ME, Wang PS, Lara C et al. Treatment and adequacy of treatment of mental disorders among respondents to the Mexico National Comorbidity Survey. American J Psychiatry 2006;163(8):1371-1378.

  11. Wang PS, Aguilar-Gaxiola S, Alonso J, Angermeyer M et al. Use of mental health services for anxiety, mood, and substance disorders in 17 countries in the WHO world mental health surveys. Lancet 2007;370(9590): 841-850.

  12. Wang PS, Angermeyer M, Borges G, Bruffaerts R et al. Delay and failure in treatment seeking after first onset of mental disorders in the World Health Organization’s World Health Survey Initiative. World Psychiatry 2007;6(3):177-185.

  13. Wang PS, Aguilar-Gaxiola S, Alonso J et al. Delay an failure in treatment seeking after first onset of mental disorders in the World Mental Health Survey Initiative. Kessler R, Üstün TB (eds.). The WHO World Mental Health Surveys. Global perspectives on the epidemiology of mental disorders. World Health Organization. Cambridge: Cambridge University Press; 2008.

  14. Andrade L, Caraveo J, Berglund P, Arbor A et al. Cross-national comparisons of the prevalences and correlates of mental disorders. Who International Consortium in Psychiatric Epidemiology. Bulletin World Health Organization 2000;78(4):413-426.

  15. National Institute of Drug Abuse, National Institute of Health, U.S Department of Health & Human Services. Enfoques para el tratamiento de la drogadicción, 2009 http://www.biblioteca.cij.gob.mx/Archivos/Materiales_de_consulta/Tratamiento_alcohol_y_drogas/Articulos/Enfoques_de_tratamiento.pdf

  16. Power EJ, Nishimi RY, Kizer KW. Evidence-based treatment practices for substance use disorders. Washington, DC: National Quality Forum; 2005.

  17. Lazcano-Ponce E, Salazar E, Gutiérrez P, Ángeles A et al. Ensayos clínicos aleatorizados: variantes, métodos de aleatorización, análisis, consideraciones éticas y regulación. Salud Pública Méx 2004;46(6):559-584.

  18. Laporte JR. Principios básicos de investigación clínica. España: Fundació Institut Catalá de Farmacología; 2006.

  19. Fernández P. Estudios experimentales en la práctica clínica. Investigación terapéutica. Ensayos clínicos. En: Gómez de la Cámara A (ed.). Manual de Medicina Basada en la Evidencia. Elementos para su desarrollo y aplicación en atención primaria. Madrid: Jarpyo Editores; 1998. (Actualización 28/02/2001).

  20. Moher D, Shulz K, Altman D. The CONSORT Statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. JAMA 2001;285(15):1987-1991.

  21. García-Silberman S, Arana D, Martínez R, Infante R et al. La investigación sobre aspectos epidemiológicos y psicosociales de la salud mental: Un análisis bibliométrico. Salud Mental 2004;27(5):8-22.

  22. Begg C, Cho M, Eastwood S, Horton R et al. Mejora de la calidad de los informes de los ensayos clínicos aleatorios controlados. Recomendaciones del Grupo de Trabajo Consort. Rev Esp Salud Pública 1998;72:5-11.

  23. Cobos-Carbó A. Ensayos clínicos aleatorizados (CONSORT). Med Clin (Barc) 2005;125(supl 1):21-27.

  24. Sacristán JA, Soto J, Galende I. Evaluación crítica de ensayos clínicos. Med Clin (Barc) 1993;100:780-787.

  25. Saraceno B, Van Ommeren M, Batniji R, Cohen A et al. Barriers to improvement of mental health services in low-income and middle-income countries. Lancet 2007;370:1164-1174.

  26. Medina-Mora ME, Rojas E, Real T. Tendencias recientes en el panorama epidemiológico de México ¿Por qué es importante el tratamiento? En: Echeverría L, Carrascoza C, Reidl L (eds.). Prevención y tratamiento de conductas adictivas. México: Universidad Nacional Autónoma de México, Facultad de Psicología, Consejo Nacional de Ciencia y Tecnología; 2007.




2020     |     www.medigraphic.com